Boehringer Ingelheim, Veeva Launch One Medicine Platform

Boehringer Ingelheim and Veeva Systems announce the launch of Boehringer Ingelheim's One Medicine platform, supported by the successful implementation of Veeva Development Cloud. The collaboration was initially announced in March 2022.

The One Medicine platform unifies clinical, regulatory, and quality data and processes, allowing Boehringer Ingelheim to streamline product development. The integration facilitates seamless data sharing across functions, improves trial efficiency, enhances collaboration with research centers, and accelerates the delivery of new treatments for diseases with limited or no existing therapeutic options.

"Together with Veeva, Boehringer has advanced its approach to clinical trials and is fulfilling its commitment to accelerating the delivery of innovative treatments," says Oliver Fink, Director of Learning, Processes, and Digitalization, Boehringer Ingelheim. "Veeva Development Cloud provides the technological foundation for One Medicine, giving our teams the flexibility to design and execute studies with greater speed, efficiency, and compliance."

Veeva Development Cloud serves as the technology backbone for product development, integrating clinical, quality, regulatory, and safety applications to simplify business processes. By leveraging this platform, Boehringer Ingelheim aims to unify data across different teams, reducing inefficiencies and expediting drug development and approvals.

"By connecting clinical, regulatory, and quality functions in Veeva Development Cloud, Boehringer eliminates silos and accelerates drug development," says Rik van Mol, Senior Vice President, Veeva Development Cloud. "This marks an important milestone in Veeva and Boehringer's shared mission to modernize clinical trials through data and technology."

Boehringer Ingelheim is a biopharmaceutical company that focuses on human and animal health, with over 53,500 employees in more than 130 markets. The company invests significantly in R&D. Meanwhile, Veeva Systems is a global provider of cloud software for the life sciences industry. The company serves more than 1,000 clients, ranging from large pharmaceutical firms to emerging biotech companies. As a Public Benefit Corporation, Veeva balances the interests of stakeholders, including customers, employees, shareholders, and industry partners.